Back to search
FDAFDA · Food and drugs·Recall number D-0649-2024

Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04

Published September 11, 2024 · Recall initiated: August 1, 2024

Summary

FDA records drug Class I recall D-0649-2024, published September 11, 2024 and initiated August 1, 2024. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 44,208 containers; Lot: Lot # N008235, Exp 8/31/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

What to do

Voluntary: Firm initiated · Letter

Get an email if HEPARIN SODIUM IN SODIUM CHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HEPARIN SODIUM IN SODIUM CHLORIDE
Manufacturer
Baxter Healthcare Corporation
Distributor
Nationwide in the USA
Lot
Lot # N008235, Exp 8/31/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04 recalled?

Yes. FDA published recall D-0649-2024 on September 11, 2024. Reported hazard: Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HEPARIN SODIUM IN SODIUM CHLORIDE.